(2R,3S,5R)-2-(hydroxymethyl)-5-(3-methoxynaphthalen-2-yl)tetrahydrofuran-3-ol

Catalog No. :
ACRMDE312
CAS No. :
1117893-19-2
Molecular Formula :
C16H18O4
Molecular Weight :
274.32

IUPAC Name:(2R,3S,5R)-2-(hydroxymethyl)-5-(3-methoxynaphthalen-2-yl)tetrahydrofuran-3-ol

(2R,3S,5R)-2-(hydroxymethyl)-5-(3-methoxynaphthalen-2-yl)tetrahydrofuran-3-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3S,5R)-2-(hydroxymethyl)-5-(3-methoxynaphthalen-2-yl)tetrahydrofuran-3-ol
IUPAC Name(2R,3S,5R)-2-(hydroxymethyl)-5-(3-methoxynaphthalen-2-yl)tetrahydrofuran-3-ol
Molecular FormulaC16H18O4
Molecular Weight274.32
SMILESO[C@@H]1[C@@H](CO)O[C@@H](C2=C(OC)C=C3C=CC=CC3=C2)C1
InChI KeyXVSHFDVHYNHNDU-NUEKZKHPSA-N
SynonymdNaM;(2R,3S,5R)-2-(hydroxymethyl)-5-(3-methoxynaphthalen-2-yl)tetrahydrofuran-3-ol;D-erythro-Pentitol, 1,4-anhydro-2-deoxy-1-C-(3-methoxy-2-naphthalenyl)-, (1R)-;1-b-D-(3-Methoxy naphthalen-2-yl)-2’-deoxyriboside;1,4-Anhydro-2-deoxy-1-C-(3-methoxy)-phthalenyl)-D-erythro-pentitol;1,4-Anhydro-2-deoxy-1-C-(3-methoxy)-naphthalenyl)-D-erythro-pentitol
CAS No.1117893-19-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACRMDE312 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRMDE312 route product structure diagram
    ACRMDE3121117893-19-2
Inquiry

2. ACRMDE312 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRMDE312 route product structure diagram
    ACRMDE3121117893-19-2
Inquiry

Comments (0)